Cell and Gene Outsourcing

1. May 2026 — CDMO Opportunities And Threats Report 6/16/2026

   Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.

2. Bio/Pharmaceutical Facility Validation And Environmental Monitoring 6/11/2026

   Gain insight into how experienced validation and monitoring partners help organizations establish compliant operations, maintain facility performance, manage risk, and support long-term operational excellence.

3. Viral Safety Testing In Biologics: Detecting What Current Methods Miss 6/10/2026

   Biologics face unpredictable risks as complexity grows; evolving testing strategies to broaden detection, address gaps, and strengthen safety confidence without disrupting development or compliance.

4. Science With Purpose: Advancing Sustainability In Biopharma Testing 6/9/2026

   Learn how biopharma labs are cutting animal use, energy, and paper waste while maintaining GMP compliance — with specific data on 85% labor reductions and 1 ton of CO2e saved annually.

5. Plant-Based Peptones For Bioprocessing 6/9/2026

   Plant-based, animal-free peptones enhance bioprocessing by improving yields, supporting low-serum conditions, simplifying media design, and enabling consistent and compliant cell culture performance.

6. Strategic Use Of Yeast Extracts In Cell Culture 6/9/2026

   Animal-free yeast extracts enhance cell culture and fermentation by improving yields, cell health, and consistency, while supporting regulatory confidence, supply security, and media performance.

7. Peptones, Hydrolysates, And Yeast Extracts 6/9/2026

   We offer plant-based, animal-free peptones, hydrolysates, and yeast extracts in ultrafiltered and microfiltered formats, supporting cell culture, fermentation performance, and bioprocess nutrition.

8. 100% Animal-Free Production And Control 6/9/2026

   See animal-free peptones and hydrolysates enabling consistent, scalable cell culture and fermentation, with variability reduction, regulatory support, and customizable manufacturing solutions.

9. GPEx® Lightning: Stable Cell Line Development For Complex Biologics 6/5/2026

   GPEx® Lightning delivers stable cell pools in 25 days, titers exceeding 15g/L for mAbs and 11g/L for bispecifics, and 60+ generations of stability — compressing timelines by 6–12 weeks.

10. AAV Production Technology For Scalable, High-Quality Manufacturing 6/5/2026

    Plasmid-free AAV production technology enhances yield, purity, and scalability, enabling cost-efficient manufacturing, reduced variability, and consistent high-quality vectors for gene therapy.